Updated:
SurgePoint Capital
SurgePoint Capital operates out of New York as an early-stage venture firm focused on the pre-seed and seed moments where founder conviction matters more...
SurgePoint Capital
SurgePoint Capital operates out of New York as an early-stage venture firm focused on the pre-seed and seed moments where founder conviction matters more than market traction. The firm was conceived by Jacob, a Harvard Law-trained former private funds and M&A attorney, and Bradley, a quantitative trader and experienced angel investor with a mathematics background from Princeton. The two built SurgePoint on the thesis that a streamlined, founder-first structure—willing to serve as the first committed capital in a round—can secure access to technical founders who value a fund's operating help over its brand name. The firm's deployment spans software and hard science. Portfolio companies include an AI molecular simulation platform aiming to replace wet lab experiments, a humanoid robotics startup focused on hand dexterity, a programmable mRNA delivery technology, and a company building foundation models for Earth simulation starting with weather. Other holdings cover AI-native fraud investigation, automated electronic circuit board design, voice agents indistinguishable from humans, demand forecasting for grocery retailers, grid-connected battery storage optimization, and a Canadian lending-focused neobank. SurgePoint acts as a direct investor at the earliest stages, targeting technical founders in North America. SurgePoint's website lists over two dozen active portfolio companies without disclosing total assets, fund size, or total deployment. The firm does not publish a team size beyond its two named principals on its public-facing materials. In its own framing, the fund does not pursue immediate gains, instead emphasizing long-enduring company building and offering portfolio support across recruiting, strategy, and follow-on fundraising. What distinguishes SurgePoint structurally is its commitment to acting as a first institutional check—a posture more common among solo angels or small syndicates than among branded fund managers. The firm's legal and quantitative finance backgrounds shape an investment committee that operates without the multi-layer approval processes found in larger multi-stage funds, giving founders a singular point of contact at the formative moment of company creation.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Principals
Jacob
Bradley
Sector focus
Frequently asked questions
Who makes investment decisions at SurgePoint Capital?
The firm identifies Jacob and Bradley as its investment decision-makers. Jacob holds a J.D. from Harvard Law School and previously worked as a private funds and M&A attorney. Bradley works as a quantitative trader and has experience as an angel investor, with an A.B. in Mathematics from Princeton. The firm does not publicly name additional investment committee members or supporting staff.
What is SurgePoint Capital's investment stage focus?
SurgePoint targets the earliest stages of company formation—specifically pre-seed and seed rounds. The firm markets itself as willing to serve as a founder's first institutional commitment, which positions it ahead of most venture capital firms that typically enter at priced seed or Series A rounds.
Does SurgePoint Capital take board seats or lead rounds?
SurgePoint's public materials do not specify whether it takes board seats or formally leads rounds. Its stated posture is to provide strategic, recruiting, and fundraising support without an intrusive governance presence, suggesting a preference for acting as a supportive co-investor or follow-on participant rather than a control-oriented lead.
Which technologies does SurgePoint Capital invest behind?
The portfolio spans AI-native applications, robotics and automation, computational biology, climate and energy, and vertical SaaS. Specific subfields include AI molecular simulation, humanoid robotic dexterity, mRNA delivery platforms, Earth-system foundation models, AI-powered fraud investigation, autonomous voice agents, and battery storage optimization.
Is SurgePoint Capital raising outside capital or deploying proprietary wealth?
SurgePoint describes itself as an angel fund but has not publicly disclosed the source of its capital, whether it accepts external limited partners, or the size of any committed vehicle. The firm's AUM and fund structure remain undisclosed.
How does SurgePoint Capital differentiate its founder support from other early-stage funds?
The firm commits to operational partnership across strategy, recruiting, and fundraising, describing an approach that is responsive when needed but respectful of founder autonomy. Unlike platforms that use associates or portfolio-support teams, SurgePoint appears to deliver this support directly through its two principals, keeping the relationship concentrated.
What geographies does SurgePoint Capital invest in?
Headquartered in New York, SurgePoint's disclosed portfolio includes companies based in North America. Indicative market exposure includes U.S.-based deep-tech, AI, and fintech startups alongside at least one Canadian neobank, confirming a cross-border early-stage mandate within the region.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: